Improving glaucoma management

Article

Researchers have found that giving patients a dual therapy of bimatoprost and a beta-blocker is an effective method of lowering intraocular blood pressure (IOP) in patients with open-angle glaucoma.

Researchers have found that giving patients a dual therapy of bimatoprost and a beta-blocker is an effective method of lowering intraocular blood pressure (IOP) in patients with open-angle glaucoma.

The study consisted 89 patients with an IOP of less than 21 mm Hg. During six weeks the group were given latanoprost 50 mcg plus timolol 5 mg/mL, these patients were randomized to either travoprost plus timolol or bimatoprost plus timolol for three months before switching to the opposite therapy for an additional three months.

This study has been published in the American Journal of Ophthalmology

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.